To assess the diagnostic and prognostic ability of CXRs in COVID-19 pneumonitis

H. Ahmad (Harlow, United Kingdom), S. Soman (Harlow, United Kingdom), R. Varghese (Harlow, United Kingdom), K. Dewan (Harlow, United Kingdom), R. Chapman (Harlow, United Kingdom), J. Tong (Harlow, United Kingdom), R. Kumari (Harlow, United Kingdom), U. Ekeowa (Harlow, United Kingdom), R. Ragatha (Harlow, United Kingdom), P. Russell (Harlow, United Kingdom), S. Kuckreja (Harlow, United Kingdom), M. Long (Harlow, United Kingdom), M. Anwar (Harlow, United Kingdom)

Source: International Congress 2022 – COVID 19: intensive care unit treatment

Session: COVID 19: intensive care unit treatment
Session type: Thematic Poster
Number: 2776

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ahmad (Harlow, United Kingdom), S. Soman (Harlow, United Kingdom), R. Varghese (Harlow, United Kingdom), K. Dewan (Harlow, United Kingdom), R. Chapman (Harlow, United Kingdom), J. Tong (Harlow, United Kingdom), R. Kumari (Harlow, United Kingdom), U. Ekeowa (Harlow, United Kingdom), R. Ragatha (Harlow, United Kingdom), P. Russell (Harlow, United Kingdom), S. Kuckreja (Harlow, United Kingdom), M. Long (Harlow, United Kingdom), M. Anwar (Harlow, United Kingdom). To assess the diagnostic and prognostic ability of CXRs in COVID-19 pneumonitis. 2776

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.